![No image](https://static.cymitquimica.com/public/img/logo-cymit-gray.png)
CAS 2173992-01-1: 3-Azetidinamine, 1-(1,3,4-thiadiazol-2-yl)-, hydrochloride (1:2)
Formula:C5H8N4S·2ClH
InChI:InChI=1S/C5H8N4S.2ClH/c6-4-1-9(2-4)5-8-7-3-10-5;;/h3-4H,1-2,6H2;2*1H
InChI key:InChIKey=GRURSWRPQBZMRZ-UHFFFAOYSA-N
SMILES:Cl.N=1N=C(SC1)N2CC(N)C2
- Synonyms:
- 3-Azetidinamine, 1-(1,3,4-thiadiazol-2-yl)-, hydrochloride (1:2)
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | 1-(1,3,4-thiadiazol-2-yl)azetidin-3-amine dihydrochloride REF: IN-DA00IKZDCAS: 2173992-01-1 | 97% | 134.00 €~316.00 € | Tue 04 Mar 25 |
![]() | 1-(1,3,4-Thiadiazol-2-yl)azetidin-3-amine dihydrochloride REF: 3D-YLD99201CAS: 2173992-01-1 | Min. 95% | To inquire | Tue 15 Apr 25 |
![]() | 1-(1,3,4-Thiadiazol-2-yl)azetidin-3-aminehydrochloride REF: 10-F696149CAS: 2173992-01-1 | 97% | - - - | Discontinued product |
![discount label](https://static.cymitquimica.com/public/img/discount.png)
1-(1,3,4-thiadiazol-2-yl)azetidin-3-amine dihydrochloride
CAS:2173992-01-1
Formula:
C5H10Cl2N4S
Purity:
97%
Color and Shape:
Solid
Molecular weight:
229.1307
Ref: IN-DA00IKZD
1g | 316.00 € | ||
100mg | 134.00 € | ||
250mg | 179.00 € | ||
500mg | 213.00 € |
Estimated delivery in United States, on Tuesday 4 Mar 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
1-(1,3,4-Thiadiazol-2-yl)azetidin-3-amine dihydrochloride
CAS:2173992-01-1
Versatile small molecule scaffold
Formula:
C5H10Cl2N4S
Purity:
Min. 95%
Molecular weight:
229.13 g/mol
Ref: 3D-YLD99201
250mg | 457.00 € | ||
2500mg | 1,440.00 € |
Estimated delivery in United States, on Tuesday 15 Apr 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
1-(1,3,4-Thiadiazol-2-yl)azetidin-3-aminehydrochloride
CAS:2173992-01-1
Purity:
97%
Molecular weight:
192.6699981689453
Ref: 10-F696149
1g | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |